1. Home
  2. HCWB vs EPSM Comparison

HCWB vs EPSM Comparison

Compare HCWB & EPSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HCWB

HCW Biologics Inc.

HOLD

Current Price

$2.66

Market Cap

14.8M

Sector

Health Care

ML Signal

HOLD

Logo Epsium Enterprise Limited Ordinary Shares

EPSM

Epsium Enterprise Limited Ordinary Shares

HOLD

Current Price

$1.33

Market Cap

17.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCWB
EPSM
Founded
2018
2010
Country
United States
China
Employees
N/A
17
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.8M
17.0M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
HCWB
EPSM
Price
$2.66
$1.33
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$35.00
N/A
AVG Volume (30 Days)
93.4K
57.9K
Earning Date
05-15-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.37
N/A
Revenue
$4,099,750.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$7.78
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.25
$0.83
52 Week High
$7.35
$155.00

Technical Indicators

Market Signals
Indicator
HCWB
EPSM
Relative Strength Index (RSI) 43.29 51.12
Support Level $0.37 $1.26
Resistance Level $3.89 $1.53
Average True Range (ATR) 0.35 0.11
MACD -0.26 0.01
Stochastic Oscillator 3.05 56.27

Price Performance

Historical Comparison
HCWB
EPSM

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.

About EPSM Epsium Enterprise Limited Ordinary Shares

Epsium Enterprise Ltd is a holding company and conducts business through its subsidiaries. It is engaged in import trading and wholesale selling of beverages in Macau. The company imports and sells a range of beverages, alcoholic beverages, and a small quantity of tea and fruit juice. The alcoholic beverages it sells include Chinese liquor, French cognac, Scottish whiskey, fine wine, Champagne, and other miscellaneous beverage alcohols.

Share on Social Networks: